To date, no data are available from clinical studies that were specifically-designed to evaluate the safety of Rasilez HCT in diabetic patients.
Seni puuduvad andmed kliinilistest uuringutest, mis oleksid spetsiaalselt hinnanud Rasilez HCT ohutust diabeetikutel.